Provisional Public Health Service Inter-Agency Recommendations for Screening Donated Blood and Plasma for Antibody to the Virus Causing Acquired Immunodeficiency Syndrome

CDC. Prevention of acquired immune deficiency syndrome (AIDS): Report of inter-agency recom- mendations. MMWR 1983; 32:101-3.

Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retrovi- ruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984 224:500-3.

Barre-Sinoussi F, Chermann JC, Rer F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.

Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oschiro LS. Isolation of lymphocy- topathic retroviruses from San Francisco patients with AIDS. Science 1984:225:840-2.

Sarngadharan MG, Popovic M. Bruch L, Schipbach J, Gallo RC. Antibodies reactive with human T- lymphotropic retroviruses (HTLY-illl) in the serum of patients with AIDS. Science 1984,224-506-8.

Safai B, Sarngadharan MG. Groopman JE, et al. Seroepidemiological studies of human T- lymphotropic retrovirus type Il in acquired immunodeficiency syndrome. Lancet 1984; 1438-40.

Laurence J.Brun-Vezinet F.Schutzer SE, et al. Lymphadenopathy associated viral antibody in AIDS. N Engl J Med 1984;311:1269-73.

Melbye M, Biggar RJ, Ebbesen P. et al. Seroepidemiology of HTLV-III antibody in Danish homosexu- al men: prevalence, transmission, and disease outcome. Brit Med J 1984, 289:573-5-5.

CDC. Antibodies to a retrovirus etiologically associated with acquired immundeficiency syndroine (AIDSI in populations with increased incidences of the syndrome. MMWWWR 1984; 33:377-9.

Weiss SH, Goedert JJ, Samgadharan MB, et al. Screening test for HTLV-III (AIDS agent) antbodies: specificity, sensitivity, and applications. JAMA 1985; 253:221-5.

Goedert JU. Sarngadharan MG, Biggar RJ, et al. Determinants of retrovirus (HTLV-ll antibody and immunodeficiency conditions in homosexual men. Lancet 1984;2:711-16.

Spira TJ, Des Jarlais DC, Marmor M, et al. Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N EngI J Med 1984:311:467-8.

Ramsey RB, Palmer EL, McDougal JS, et al. Antibody to lymphadenopathy-associated virus in hemophiliacs with and without AIDS. Lancet 1984;2:397-8.

Tsoukas C, Gervais F, Shuster J, Gold P, O'Shaughnessy M. Robert-Guroff M. Association of HTLV- Ill antibodies and cellular immune status of hemophiliacs. N Engl J Med 1984;31:1514-15.

Harris CA, Cabradila C, Klein RS, et al. Antibodies to a core protein (p25) of lymphadenopathy as- sociated virus (LAV) and immunodeficiency in heterosexual partners of AIDS patients. Presentation at 24th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 1984.

Anonymous. Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet 1984; 2:1376-7.

Salahuddin SZ, Groopman JE, Markham PD, et al. HTLV-ll in symptom-free seronegative persons. Lancet 1984; 2:1418-20.

Groopman JE.Unpublished data.

Groopman JE, Salahuddin SZ, Sarngadharan MG, et al. HTLV-III in saliva of people with AIDS- related complex and healthy homosexual men at risk for AIDS. Science 1984, 226:447-9.

Zagury D. Bernard Leibowitch J, J, et al. HTLV-II in cells cultured from semen of two patients with AIDS. Science 1984;226:449-51.

Feorino PM, Jaffe HW, Palmer E, et al. Transfusion-associated acquired immundeficiency syn- drome: evidence for persistent infection in blood donors. Submitted for publication.

Darrow WW. Jaffe HW, Braff E, et al. Acquired immunodeficiency syndrome (AIDS) in a cohort of homosexual men. Presentation at 24th Interscience Conference on Antimicrobial Agents and Che- motherapy. Washington, D.C., 1984.

Tsang VCW, Peralta JM, Simons AR. Enzyme-linked immuncelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol 1983 ;92:377-91.